Avalyn Pharma Inc.

Q: Jun 30 2026

Q: Mar 31 2026

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Regulation FD Disclosure

Results of Operations and Financial Condition

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Prospectus Supplement with Pricing Information

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

Notice of Effectiveness

Amended Initial Registration Statement

Certification of approval for listing and registration on a national securities exchange

Registration of Securities on Exchange

Amended Initial Registration Statement

Registration (IPO) statement under Securities Act of 1933

06b

06b

<ITEMS>06b

06b

06b

06b

06

Meyer Robert J.

Meyer Robert J.

Novo Holdings A/S

Norwest Venture Partners XV, LP

FMR LLC

SR ONE CAPITAL MANAGEMENT, LLC

SUVRETTA CAPITAL MANAGEMENT, LLC

PERCEPTIVE ADVISORS LLC

Novo Holdings A/S

FMR LLC

FMR LLC

Golden Adam H.

Carlson Douglas R

Baranowski Lyn

Lavelle Erin

Lazarus Howard

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.

Haviland Kate

Rhodes Melissa

Turner Heather D

Draft registration statement (confidential submission) (amendment)

Draft registration statement (confidential submission)